tradingkey.logo
tradingkey.logo
Suchen

Sotera Health Co

SHC
Zur Watchlist hinzufügen
17.380USD
0.0000.00%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
4.96BMarktkapitalisierung
41.92KGV TTM

mehr Informationen über Sotera Health Co Unternehmen

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Sotera Health Co Informationen

BörsenkürzelSHC
Name des UnternehmensSotera Health Co
IPO-datumNov 20, 2020
CEOPetras (Michael B)
Anzahl der mitarbeiter3000
WertpapierartOrdinary Share
GeschäftsjahresendeNov 20
Addresse9100 South Hills Blvd, Suite 300
StadtBROADVIEW HEIGHTS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl44147
Telefon14402621410
Websitehttps://soterahealth.com/
BörsenkürzelSHC
IPO-datumNov 20, 2020
CEOPetras (Michael B)

Führungskräfte von Sotera Health Co

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
140.93K
+10.62%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
95.75K
+15.63%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
95.75K
+15.63%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
54.19K
+27.62%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--
Mr. Constantine S. (Dean) Mihas
Mr. Constantine S. (Dean) Mihas
Independent Director
Independent Director
--
--
Dr. David E. Wheadon, M.D.
Dr. David E. Wheadon, M.D.
Independent Director
Independent Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Independent Director
Independent Director
--
--
Mr. Michael B. Petras, Jr.
Mr. Michael B. Petras, Jr.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
140.93K
+10.62%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
95.75K
+15.63%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
95.75K
+15.63%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
54.19K
+27.62%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Sotera Health Co?

Die fünf größten Anteilseigner von Sotera Health Co sind: Ms. Ann R. Klee

Wie viele Institutionen halten Anteile an Sotera Health Co (SHC)?

Mit Stand vom 2026Q1 halten 534 Institutionen Anteile an Sotera Health Co, mit einem Gesamtmarktwert von etwa 269.76M, was 94.60% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 20759750.00 gestiegen.
KeyAI